Remus Pharmaceuticals Ltd vs Rpg Life Sciences Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Remus Pharmaceuticals Ltd is ₹ 714 as of 05 May 14:44 . The P/E Ratio of Remus Pharmaceuticals Ltd is 49.4 as of March 2024 .The P/E Ratio of RPG Life Sciences Ltd is 0 as of March 2024 . The Market Cap of Remus Pharmaceuticals Ltd is ₹ 1016 crore as of March 2024 .The Market Cap of RPG Life Sciences Ltd is ₹ 0 crore as of March 2024 . The revenue of Remus Pharmaceuticals Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of RPG Life Sciences Ltd for the Mar '26 is ₹ 190.39 crore as compare to the Dec '25 revenue of ₹ 183.44 crore. This represent the growth of 3.79% The ebitda of Remus Pharmaceuticals Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of RPG Life Sciences Ltd for the Mar '26 is ₹ 46.33 crore as compare to the Dec '25 ebitda of ₹ 34.75 crore. This represent the growth of 33.32% The net profit of Remus Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 6 quarters. This represents a CAGR of 0.0% The net profit of RPG Life Sciences Ltd changed from ₹ 34.93 crore to ₹ 29.9 crore over 6 quarters. This represents a CAGR of -9.85% The Dividend Payout of Remus Pharmaceuticals Ltd changed from 2.56 % on March 2023 to 4.44 % on March 2025 . This represents a CAGR of 20.15% over 3 yearsThe Dividend Payout of RPG Life Sciences Ltd changed from 29.77 % on March 2021 to 21.66 % on March 2025 . This represents a CAGR of -6.16% over 5 years .

About Remus Pharmaceuticals Ltd

Remus Pharmaceuticals Limited was originally incorporated as Remus Pharmaceuticals Private Limited' as a Private Limited Company, vide Certificate of Incorporation dated September 21, 2015, issued by the Assistant Registrar of Companies, Gujarat.
Subsequently, Company converted from a Private to Public and the name of the Company was changed to 'Remus Pharmaceuticals Limited' on January 06, 2023 by the Registrar of Companies, Ahmedabad. The Company is engaged in marketing & distribution of finished formulations of pharmaceutical drugs.
It deals in API (Active Pharmaceutical Ingredient), provide technical consultancy services to various distributors for preparation of reports on the dossiers of the products to be registered by them in various countries.
The Company deal in drug forms like Capsules, Cream, Eye Drops, Gel, Infusion, Inhalation, Inhaler, Injection, Nail Lacquer, Nasal Solution, Nasal Spray, Nebuliser, Ointment, Ophthalmic, Oral Gel, Oral Solution, Oral Suspension, Sachet, Suspension, Tablet.

About RPG Life Sciences Ltd

RPG Life Sciences Limited, formerly known as Searle India Limited, started in 1968 as a joint venture with GD Searle, USA. In 1993, GD Searle withdrew from India and sold its holdings to RPG Group.
The Company is engaged in manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). RPG Life Sciences Limited was incorporated on March 29, 2007 with the name 'RPG Pharmaceuticals Limited'.
During the year 2007-08, as per the Scheme of Arrangement, the Company acquired the Pharmaceuticals Business of Brabourne Enterprises Limited along with all assets and liabilities pertaining to that business with effect from April 2, 2007.
On February 13, 2008, the name of the Company was changed to RPG Life Sciences Limited. During the year 2008-09, the company increased the production capacity of Bulk Drugs and Chemicals from 62 tonnes to 71 tonnes.

FAQs for the comparison of Remus Pharmaceuticals Ltd and RPG Life Sciences Ltd

Which company has a larger market capitalization, Remus Pharmaceuticals Ltd or RPG Life Sciences Ltd?

Market cap of Remus Pharmaceuticals Ltd is 844 Cr while Market cap of RPG Life Sciences Ltd is 4,008 Cr

What are the key factors driving the stock performance of Remus Pharmaceuticals Ltd and RPG Life Sciences Ltd?

The stock performance of Remus Pharmaceuticals Ltd and RPG Life Sciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Remus Pharmaceuticals Ltd and RPG Life Sciences Ltd?

As of May 5, 2026, the Remus Pharmaceuticals Ltd stock price is INR ₹716.8. On the other hand, RPG Life Sciences Ltd stock price is INR ₹2423.8.

How do dividend payouts of Remus Pharmaceuticals Ltd and RPG Life Sciences Ltd compare?

To compare the dividend payouts of Remus Pharmaceuticals Ltd and RPG Life Sciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.